Form 8-K · Current report
Visa Inc. 8-K, filed Jul 28, 2026
- Filed
- CIK
- 0001403161
- Accession no.
- 0001403161-26-000103
Summary
Visa Inc. reported fiscal third-quarter 2026 results for the quarter ended June 30, 2026, with net revenue of $11.6 billion, GAAP net income of $5.6 billion ($2.97 per share) and non-GAAP net income of $6.3 billion ($3.32 per share). Visa's board also declared a quarterly cash dividend of $0.670 per share payable September 1, 2026, to holders of record as of August 11, 2026.
Key points
- Visa reported fiscal third-quarter 2026 net revenue of $11.6 billion, up 14% year over year, with GAAP net income of $5.6 billion ($2.97 per share) and non-GAAP net income of $6.3 billion ($3.32 per share).
- Payments volume rose 10%, total cross-border volume rose 13%, and processed transactions rose 10% to 71.7 billion.
- Visa's board declared a quarterly cash dividend of $0.670 per share of class A common stock, payable September 1, 2026, to holders of record as of August 11, 2026.
- CEO Ryan McInerney said consumer and business spending remains resilient; Visa repurchased about 14.5 million class A shares for $4.9 billion during the quarter.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On July 28, 2026, Visa Inc. (the "Company") issued an earnings release announcing financial results for the Company's fiscal third quarter ended June 30, 2026. A copy of the earnings release is attached hereto as Exhibit 99.1. All information in the earnings release is furnished but not filed. On July 28, 2026, the Company will host a conference call to discuss its fiscal third quarter ended June 30, 2026 financial results. Item 8.01 Other Events. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.